Progress and Challenges in Asia-Pacific's Goal to Eliminate Malaria by 2030
The World Malaria Report 2025 indicates a mixed outlook for the Asia-Pacific region. While estimated cases in Southeast Asia have dropped from 9.6 million in 2023 to 8.9 million in 2024, challenges like drug resistance and funding gaps persist. India has set a target to achieve zero indigenous malaria cases by 2027 and complete elimination by 2030. The introduction of the RTS,S and R21 vaccines offers hope, particularly for high-burden areas. However, the emergence of artemisinin-resistant malaria in the Greater Mekong Subregion and a significant funding shortfall of $2.4 billion in 2024 threaten the 2030 goal.
Key Points
- India aims for zero indigenous malaria cases by 2027 and total elimination by 2030.
- Five states in India's northeast account for nearly 80% of the country's malaria burden.
- The R21/Matrix-M vaccine has shown high efficacy in clinical trials and is being rolled out in Africa.
- A funding gap of $2.4 billion was reported globally in 2024 for malaria programs.
Exam Facts
- India's target for zero indigenous cases is 2027.
- Global funding gap for malaria in 2024 was $2.4 billion.
- Southeast Asia malaria cases dropped to 8.9 million in 2024.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.